Recent Advances in the Pathogenesis, Prevention and Management of Type 2 Diabetes and its Complications

preface_ Recent Advances in the Pathogenesis, Prevention and Management of Type 2 Diabetes and its Complications......Page 1 Part 1 _Diabetic Neuropathy......Page 13 01_New Treatment Strategies in Diabetic Neuropathy......Page 15 02_Sonographic Imaging of the Peripheral Nerves in Patients with Type 2 Diabetes Mellitus......Page 27 03_Diabetic Neuropathy – Nerve Morphology in the Upper Extremity......Page 45 Part 2 _ Diabetes and Cardiovascular Disease......Page 55 04_Residual Vascular Risk in T2DM: The Next Frontier......Page 57 05_Type 2 Diabetes and Fibrinolysis......Page 79 06_Diabetes and Aspirin Resistance......Page 103 07_Diabetic Cardiomyopathy......Page 117 08_AF and Diabetes Prognosis and Predictors......Page 131 09_Detection of Silent Ischemia in Patients with Type 2 Diabetes......Page 141 10_Effects of Type 2 Diabetes on Arterial Endothelium......Page 167 Part 3 _Hypertension, Nephropathy and Diabetes......Page 191 11_Antihypertensive Treatment in Type 2 Diabetic Patients......Page 193 12_Managing Hypertension in Patients with Diabetes......Page 219 13_Treatments for Hypertension in Type 2 Diabetes-Non-Pharmacological and Pharmacological Measurements......Page 245 14_Diabetic Nephropathy; Clinical Characteristics and Treatment Approaches......Page 275 15_Anemia of Chronic Kidney Disease in Diabetic Patients: Pathophysiologic Insights and Implications of Recent Clinical Trials......Page 285 16_A Diachronic Study of Diabetic Nephropathy in Two Autochthonous Lines of Rats to Understand Diabetic Chronic Complications......Page 295 Part 4 _Diverse Organ Involvement Dysfunction in Diabetes......Page 313 17_Pathogenic Features of Insulin Resistance and Critical Organ Damage in the Liver, Muscle and Lung......Page 315 18_Implications of Type II Diabetes Mellitus on Gastrointestinal Cancers......Page 335 19_Prevention for Micro- and Macro-Vascular Complications in Diabetic Patients......Page 349 Part 5 _Aspects of the Treatment of Type 2 Diabetes......Page 385 20_Emerging Challenge of Type 2 Diabetes: Prospects of Medicinal Plants......Page 387 21_Nutritional Therapy in Diabetes: Mediterranean Diet......Page 403 22_Pharmacogenetics for T2DM and Anti-Diabetic Drugs......Page 425 Type 2 diabetes "mellitus" affects nearly 120 million persons worldwide- and according to the World Health Organization this number is expected to double by the year 2030. Owing to a rapidly increasing disease prevalence, the medical, social and economic burdens associated with the microvascular and macrovascular complications of type 2 diabetes are likely to increase dramatically in the coming decades. In this volume, leading contributors to the field review the pathogenesis, treatment and management of type 2 diabetes and its complications. They provide invaluable insight and share their discoveries about potentially important new techniques for the diagnosis, treatment and prevention of diabetic complications